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Background: Lyme disease in the United States is caused primarily by B. burgdorferi sensu stricto while other
species are also prevalent in Europe. Genetic techniques have identified several chromosomal and plasmid-borne
regulatory and virulence factors involved in Lyme pathogenesis. B31 and N40 are two widely studied strains of B.
burgdorferi, which belong to two different 16 S-23 S rRNA spacer types (RST) and outer surface protein C (OspC)
allelic groups. However, the presence of several known virulence factors in N40 has not been investigated. This is
the first comprehensive study that compared these two strains both in vitro and using the mouse model of
infection.
Results: Phylogenetic analyses predict B31 to be more infectious. However, our studies here indicate that N40D10/
E9 is more infectious than the B31 strain at lower doses of inoculation in the susceptible C3H mice. Based-upon a
careful analyses of known adhesins of these strains, it is predicted that the absence of a known fibronectin-
glycosaminoglycan binding adhesin, bbk32, in the N40 strain could at least partially be responsible for reduction in
its binding to Vero cells in vitro. Nevertheless, this difference does not affect the infectivity of N40D10/E9 strain. The
genes encoding known regulatory and virulence factors critical for pathogenesis were detected in both strains.
Differences in the protein profiles of these B. burgdorferi strains in vitro suggest that the novel, differentially
expressed molecules may affect infectivity of B. burgdorferi. Further exacerbation of these molecular differences
in vivo could affect the pathogenesis of spirochete strains.
Conclusion: Based upon the studies here, it can be predicted that N40D10/E9 disseminated infection at lower
doses may be enhanced by its lower binding to epithelial cells at the site of inoculation due to the absence of
BBK32. We suggest that complete molecular analyses of virulence factors followed by their evaluation using the
mouse infection model should form the basis of determining infectivity and pathogenicity of different strains rather
than simple phylogenetic group analyses. This study further emphasizes a need to investigate multiple invasive
strains of B. burgdorferi to fully appreciate the pathogenic mechanisms that contribute to Lyme disease
manifestations.
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Lyme disease is a multisystemic disease caused by Borre-
lia burgdorferi, which is transmitted by Ixodes ticks in
the United States of America [1,2]. The earliest clinical
sign of Lyme disease is an expanding rash at the site of
tick bite known as erythema migrans [3]. If left un-
treated, infection with Lyme spirochetes can disseminate
to joints, heart, skin and central nervous system [3]. A
resulting persistent infection of the host can then result
in the development of arthritis, carditis, or neuroborre-
liosis [4]. Arthritis is the primary manifestation of late
and chronic Lyme disease by B. burgdorferi sensu stricto,
the predominant genospecies in the United States.
The genetic basis of bacterial virulence and disease
has been investigated in a large number of Gram-
negative and Gram-positive bacteria in the last three
decades and major virulence factors of each microbe
have been identified. These studies have shown that vari-
ous strains of bacterial pathogens often exhibit different
levels of pathogenicity and disease manifestations in the
hosts. In most cases, the high pathogenicity is associated
with specific variations in the set of virulence factors
[5-11]. In many microbes, the respective virulence
factor-encoding genes are clustered together in specific
regions defined as pathogenicity islands [12]. Strains of
B. burgdorferi show a high variation in their ability to
cause disseminated infection. Since genetic studies have
been developed in this spirochete only in the past dec-
ade, classification based upon its virulence factor diver-
sity has not yet been fully developed. Furthermore, the
presence of a segmented genome has hampered studies
with different spirochete strains. However, B. burgdorferi
sensu stricto strains have been divided into different
groups either on the basis of allelic variation in the
Outer surface protein C (OspC), which is essential for
causing infection in the mammalian hosts [13-16], or
the polymerase chain reaction (PCR) and restriction
fragment length polymorphism analysis of 16 S-23 S
rRNA spacer types (RST). Furthermore, ospC or RST
groups were used as markers to determine pathogenicity
of different B. burgdorferi strains with only some groups
considered invasive [17-24].
Studies involving the two most widely investigated
strains, B31 and N40, have contributed significantly to
the understanding of Lyme disease pathogenesis and
assessment of the virulence factors of B. burgdorferi
[25-27]. B31 and N40 strains were isolated from Ixodes
scapularis ticks from Shelter Island and Westchester
county of New York, respectively, and both are highly
infectious in the mouse model [2,28]. Indeed, N40
strain was selected for its high pathogenicity from a
large number of isolates recovered from ticks by Dur-
land Fish. By a thorough genetic analysis of various
clones of N40 used in various laboratories, we haverecently shown that the original culture was a mixed
culture and different researchers isolated two different
clones independently and retained the original name,
N40, for both [29]. The clones designated as cN40 and
the sequenced N40B are the derivatives of the same
strain and N40 clone D10/E9 (N40D10/E9) and N40C
appear to be derivatives of the second strain that is dif-
ferent from cN40/N40B. Comparative genomic analyses
have indicated substantial genetic diversity between B31
and N40B [30]. For example, N40B possesses a smaller
linear chromosome and contains fewer endogenous
plasmids than the B31 strain [30]. To avoid further con-
fusion, we will define specific N40 strains described
above and in our recently published paper to determine
their relevance to the published literature on these
strains [29]. Genotyping by the pulsed field gel electro-
phoresis (PFGE) method defined the B31 strain as PFG
type B and the cN40 strain as PFG type E [31]. In
addition, the B31 strain belongs to the RST1 group
while the cN40 strain is in the RST3 group [23]. Inter-
estingly, a higher proportion of the B. burgdorferi
strains isolated from patients with disseminated Lyme
disease belong to the RST1 group [23,24,32]. Therefore,
several researchers have concluded that RST1 group B.
burgdorferi strains are more infectious and pathogenic
than those of other groups [32,33]. Although several
strains belonging to the RST3 group cause disseminated
infection infrequently [23,24,32], a further subclassifica-
tion showed that some strains of RST3B can result in a
significant disease [32]. Based upon comparative ana-
lyses of the selected B. burgdorferi ospC sequence and
RST1 and RST3 group strains [21,32-34] it is some-
times erroneously concluded that cN40 (RST3B, ospC
type E) or N40D10/E9 (RST3B, ospC type M) could be
less virulent than the B31 (RST1, ospC type A) strain.
However, numerous experimental studies have estab-
lished that cN40 is highly pathogenic in various animal
models [35-39]. We, and others, have been studying
N40D10/E9 for more than a decade and found that this
strain is also highly virulent in the mouse model. How-
ever, a systematic comparative analysis of N40 strains
with the sequenced B31 strain was not conducted to
determine if both are equally pathogenic or N40 strains
are indeed less virulent than B31.
Adherence is often the first step in establishment of
infection by pathogenic bacteria and colonization of host
tissues. Lyme spirochetes are primarily extracellular, tis-
sue tropic pathogens and are found adherent to the host
cells and extracellular matrix both in the patients’ sam-
ples and mouse tissue sections, suggesting important
roles played by binding mechanisms in tissue
colonization. Furthermore, binding to host cells is likely
to be critical for B. burgdorferi facilitating selection of
suitable niche for their growth and promoting
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tissues could then allow Lyme spirochetes to escape im-
mune system in some cases [40]. Indeed, a variety of
host receptors and spirochetal adhesins are implicated in
adherence and tissue colonization [41-46]. Glycosamino-
glycans (GAGs) are the most abundant ubiquitously
expressed molecules on mammalian cell surfaces and as
components of the extracellular matrix (ECM). They are
likely to be the first molecules recognized by B. burgdor-
feri on the host cell surface due to initial charge-based
interactions. GAGs are long, unbranched polysaccharide
molecules consisting of disaccharide repeats of modified
sugars and uronic acids [47]. Based on the degree of sul-
fation and the composition of the disaccharides, they are
classified into heparin, heparan sulfate, chondroitin sul-
fate A, dermatan sulfate, chondroitin sulfate C, and ker-
atan sulfate [48]. GAGs are usually covalently linked to
protein cores to form proteoglycans. A previous study
has shown that Lyme spirochetes do not recognize kera-
tan sulfate [49]. In B. burgdorferi, several adhesins
recognize GAGs and proteoglycans. We previously iden-
tified Borrelia glycosaminoglycan-binding protein (Bgp),
an outer membrane protein that binds heparin and der-
matan sulfate, and facilitates binding of B. burgdorferi to
epithelial cells and glial cells [50]. In addition, the B.
burgdorferi surface lipoproteins decorin-binding proteins
A and B (DbpA and DbpB) recognize both decorin and
dermatan sulfate [43,51,52]. An additional adhesin,
BBK32 (fibronectin binding protein) is a surface lipo-
protein that can bind both fibronectin and GAGs to pro-
mote binding of B. burgdorferi to various mammalian
cells [41,53]. P66 recognizes the integral membrane in-
tegrin receptor and was first identified as an adhesin in
the N40D10/E9 strain [54,55] and was also shown to
express in the B31 strain [56,57]. Hence, multiple ad-
herence mechanisms are present in B. burgdorferi em-
phasizing its importance in causing multisystemic
Lyme disease.
To evaluate the molecular mechanisms involved in B.
burgdorferi tissue colonization and multisystemic disease
during mammalian infection, many different types of
host cell lines can be employed to investigate adherence
[58-64]. For example, Vero cells, which were derived
from monkey kidney epithelium [65], can be used as a
representative of epithelial cells for studying GAGs-
mediated adherence. The EA.hy926 cell line was derived
from human umbilical vein endothelial cells, and it has
been shown to express differentiated functions that are
characteristics of human vascular endothelium [66,67].
C6 glioma cells were derived from rat central nervous
system and were previously shown to display glycosami-
noglycans, heparan sulfate and chondroitin sulfates, on
their surface [43,61,68]. The T/C-28a2 cell line was
developed from human chondrocyte cells [69], whichwere shown to express fibronectin, decorin and derma-
tan sulfate [70,71]. We have used these cell lines to com-
pare the differential adherence abilities of N40D10/E9
and B31 strains.
The mouse is the natural host for B. burgdorferi and
the laboratory mouse model has been used to study in-
fectivity and pathogenicity of Lyme spirochetes. Differ-
ent strains of immunocompetent mice develop different
degrees of pathology upon infection with B. burgdorferi.
For example, C57BL/6 mice develop mild carditis and
arthritis even though colonization of the tissues is rela-
tively similar to that of disease-susceptible C3H mice
[72,73]. Arthritis development in BALB/c mice is
dependent upon infectious dose, where higher doses
caused more severe disease [72]. In contrast, C3H mice
develop severe carditis and arthritis with low infectious
doses [72,73]. Differential levels and types of localized
cytokines production have been attributed to the disease
severity in these strains of mice [74,75]. Although some
laboratories use other mouse systems [76-80], C3H mice
are ideal for discrimination of the infectivity and patho-
genicity of different B. burgdorferi strains.
In this study, we assessed the presence of known crit-
ical virulence factor encoding genes in both B31 and
N40D10/E9 strains. We employed various techniques for
comparative analyses of B31 and N40D10/E9 strains to
show that both spirochetes possess ability to bind to
various mammalian cells in vitro, can colonize different
tissues during infection and cause multisystemic disease
in the immunocompetent C3H mice. Interestingly,
N40D10/E9 is more infectious than B31 when lower
dose of inoculum is used.
Results
B. burgdorferi strain B31 binds better to Vero epithelial
cells than N40D10/E9
It has been shown previously that B. burgdorferi strain
N40D10/E9 binds efficiently to Vero epithelial cells
[49,58]. A comparison of binding of the B. burgdorferi
strains B31 and N40D10/E9 to Vero cell monolayers
in vitro showed that 25% of B31 and 15% of N40D10/E9
spirochetes remained bound when the cells were mock-
treated (Figures 1A and 1B). We previously showed that
heparin-related molecules mediate binding of N40D10/
E9 strains to the Vero cells [61,62]. When the cells were
treated with heparinase I to cleave heparan sulfate from
the cell surface and removed by washing, the binding of
B31 was reduced by 20%. Although this binding reduc-
tion was statistically significant (p = 0.014) as determined
by t-test, decrease in binding of N40D10/E9 to Vero
cells was more pronounced with approximately 67% re-
duction when heparan sulfate was removed from cells by
heparinase I (Figures 1A and 1B). Chondroitinase ABC
can cleave chondroitin sulfate A, chondroitin sulfate B
Figure 1 Binding of B. burgdorferi strains B31 (A and C) and
N40D10/E9 (B and D) to both Vero (epithelial) cells and EA.
hy926 (endothelial) cells is mediated by heparan sulfate. (A)
and (B). Vero cell monolayers were pretreated with the buffer alone
(Mock), or with the GAG lyases, heparinase I (HI) to remove heparan
sulfate or chondroitinase ABC (Chon. ABC), to cleave chondroitin
sulfates from the cell surfaces. Binding of B31 (A) to the Vero cells
was significantly higher than that of the N40D10/E9 (B) strain.
Although inhibition of binding of both N40D10/E9 and B31 was
significant, reduction in binding was more pronounced by N40D10/
E9 than B31 when Vero cells were treated with HI (p < 0.05). (C) and
(D). EA.hy926 cell monolayers were mock-treated, or pretreated with
HI or Chon. ABC enzymes. Removal of heparan sulfate from EA.
hy926 cells eliminated the binding of both B31 and N40D10/E9
strains to these cells. The experiments were repeated at least three
times using four replicates for each treatment. Each value represents
the mean± SD of quadruplicate samples. Asterisks indicate
significant reduction (p < 0.05) in binding percentage compared to
mock-treated cells as determined by t-test for pairwise comparison
of samples with unequal variance.
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ever, there was no significant change in the binding of
either B31 or N40D10/E9 strains when the Vero cells
were treated with chondroitinase ABC, indicating that
dermatan sulfate and other chondroitin sulfates do not
contribute to the binding of Lyme spirochetes to these
cells. Since B. burgdorferi does not bind keratan sulfate
glycosaminoglycan [49], the remaining 80% residual
binding of B31 and approximately 33% residual
N40D10/E9 binding to Vero cells after heparan sulfate
removal indicate that both strains may also bind to the
Vero cells using a GAG-independent pathway. The role
of these mechanism(s) is significantly higher in adher-
ence of B31 to Vero cells.
Attachment of B. burgdorferi strains B31 and N40D10/E9
to EA.hy926 endothelial cells is also mediated by heparan
sulfate
To study whether B. burgdorferi strains B31 and
N40D10/E9 exhibit a similar pattern of interaction with
endothelium, these spirochete strains were allowed to
bind to EA.hy926 endothelial cells in vitro. Both strains
showed lower and relatively similar levels of binding to
EA.hy926 cells and 6.5% of B31 and 8% of N40D10/E9
remained bound to mock-treated EA.hy926 cells
(Figures 1C and 1D). Treatment of EA.hy926 cells with
heparinase I significantly and almost completely elimi-
nated binding of both strains to these endothelial cells
with a remnant adherence level (1% only) equivalent to
that in the empty wells control (“no cells” in Figures 1C
and 1D). Treatment with chondroitinase ABC did not
affect binding of the spirochetes to the EA.hy926 cells
relative to mock-treated endothelial cells, indicating that
either EA.hy926 cells do not express chondroitin sulfates
or these spirochete strains do not recognize chondroitin
sulfates on EA.hy926 cells (Figures 1C and 1D). These
results agree with our previous finding that heparan sul-
fate is the major receptor recognized by different Lyme
spirochetes on EA.hy926 endothelial cells [61].
Dermatan sulfate plays an important role in the binding
of B. burgdorferi to C6 glioma and T/C-28a2 cells
When B. burgdorferi strains B31 and N40D10/E9 were
allowed to bind to mock-treated C6 glioma cells, ap-
proximately 32% of each strain of spirochetes bound to
the C6 cells (Figures 2A and 2B). On treatment of C6
glioma cells with heparinase I, binding of both strains
remained unaffected as compared to mock-treated cells
(Figures 2A and 2B). Both strains showed significant
reduction in binding to C6 glioma cells after chondroitin
sulfate A, chondroitin sulfate B (dermatan sulfate), and
chondroitin sulfate C were removed by pretreatment of
these cells with chondroitinase ABC (Figures 2A and 2B).
However, we have previously shown that several B.
Figure 2 Binding of B. burgdorferi strains B31 and N40D10/E9
to C6 glioma and T/C-28a2 chondrocyte cell monolayers was
significantly reduced on pretreating these cells with
chondroitinase ABC but remain unaffected on their
pretreatment with heparinase I. The experiments were repeated
at least three times using four replicates for each treatment. Each
value represents the mean± SD of quadruplicate samples. Asterisks
indicate significant reduction (p < 0.05) in binding percentage
relative to mock-treated cells as determined by t-test for pairwise
comparison of samples with unequal variance.
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nize chondroitin sulfate A and chondroitin sulfate C
[49,61,62]. Therefore, we conclude that the adherence of
both B. burgdorferi strains to glial cells was mediated pri-
marily by dermatan sulfate.
Similarly, binding of B31 to T/C-28a2 chondrocyte
cells was reduced, by the treatment of chondroitinase
ABC, from 28% to 13% (Figure 2C). N40D10/E9 binding
was reduced from 26% to 15% (Figure 2D). Since hepari-
nase I had no significant effect on the binding of both
strains to T/C-28a2 cells (Figures 2C and 2D), adherenceof B31 and N40D10/E9 to chondrocyte cells appeared
to be mediated primarily by dermatan sulfate and
receptor(s) other than GAGs.
Majority of the known virulence factors encoding genes
of the B31 strain are also present in the N40D10/E9 strain
Since the first demonstration of the essential role of
OspC in mammalian infection using the genetic ap-
proach in 2004 [13], several molecules have been shown
to be important for causing infection and disease in the
mouse model [44,82-100]. The N40D10/E9 strain is not
yet sequenced and its plasmid profile is different from
the B31 strain [29]. Therefore, limited genomic and
proteomic analyses were conducted to compare these
two strains. To determine if these two B. burgdorferi
strains show differences in the presence of genes encod-
ing known adhesins, other virulence factors and their
regulatory proteins, we amplified these genes by PCR to
investigate and differentiate these two strains. Interest-
ingly, all previously established virulence factors encod-
ing genes were present both in B31 [101] and N40D10/
E9 strains except the bbk32 gene (Figure 3A). Two dif-
ferent size PCR products were observed in B31 when in-
ternal VlsE1 primers were used for gene amplification.
This agrees with the presence of two homologs shown in
the genome website, bbf0041 and bbj51 but only
bbf0041 (VlsE1) is functional since bbj51 has a stop
codon after 57 amino acids. However, only one vlsE1
gene was detected in N40D10/E9 probably because lp38,
which contains bbj51, is missing in this strain [29].
In another study, we compared two important, highly
variable virulence factors of B. burgdorferi, OspC and
DbpA. As expected, both of these molecules are present
in both spirochete strains but showed high sequence
variation [29]. Therefore, irrespective of the phylogenetic
grouping of these strains using RST and OspC
categorization, the presence of known virulence factors
in both strains suggests that B31 and N40D10/E9 could
possibly exhibit similar levels of pathogenicity. Further-
more, although BBK32 is an adhesin [41], previous stud-
ies showed that its absence results in a subtle infectivity
defect, exhibiting disease attenuation only at low dose of
infection [45,102,103].
Divergence of fibronectin-binding adhesin gene bbk32 in
N40D10/E9 strain
BBK32 could possibly contribute to the adherence-
mediated tissue colonization in B31 as compared to
N40D10/E9 strain but a negative PCR result is not suffi-
cient to demonstrate this difference. Since sequence di-
vergence at the priming sites may lead to unsuccessful
PCR amplification, Southern hybridization was con-
ducted to determine the presence of a homolog of bbk32
gene in the N40D10/E9 strain. Absence of a band in
Figure 3 The gene homologous to the bbk32 was not detected in N40D10/E9 strain by PCR and Southern hybridization. (A). Using the
primers in Additional Table 1, complete genes bb0153, bb0184 (csrA), bb0219, bb0268, bb0383 (bmpA), bb0647 (bosR), bba25 (dbpB), bba68 (cspA),
bbd14, bbd18, bbe22 (pncA), bbg02, bbh06 (cspZ), bbj09 (ospD), bbk17 (adeC), bbu06, and partial vlsE1 gene (using internal conserved primers) were
amplified by PCR using B31 and N40D10/E9 strains genomic DNA as template. The bbk32 gene was amplified from B31 genomic DNA, however,
PCR product was not detected in the N40D10/E9 strain. (B) Southern blot of EcoR1-digested genomic DNA of both strains (top) was hybridized
with the probe prepared using the bbk32 PCR product from B31. An approximately 1.8 kb size fragment was detected only in B31, as expected,
but not in the N40D10/E9 genomic DNA containing lane.
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shown) indicated that either bbk32 homolog in the
N40D10/E9 strain was absent or had substantial DNA
sequence divergence from that in the B31 strain
(Figure 3B). Therefore, irrespective of the presence of
BBK32, the two B. burgdorferi strains examined here
(B31 and N40D10/E9) show similar levels of binding to
most cells, indicating redundancy of function. However,
BBK32 may contribute to the binding of Lyme spiro-
chetes to specific cell line(s), such as Vero cells, and po-
tentially to epithelial cells in vivo.
B31 and N40D10/E9 showed remarkably different protein
expression profiles
Although known virulence factors are present in both
B31 and N40D10/E9 strains (Figure 3A), they only repre-
sent the molecular profile of previously identified viru-
lence factors and molecules associated with infectivity.
Therefore, it would be erroneous to conclude that they
represent the full repertoire of the virulence factors of B.
burgdorferi that play important roles during pathogenesis
in the mammalian host. Since the N40D10/E9 genome is
not sequenced, it is possible that this strain contains add-
itional virulence factors that play a role in Lyme patho-
genesis. Alternatively, specific virulence factors may be
expressed differentially in the two strains. To discern the
differences in the protein profiles of these two strains, a
comparative analysis of proteins expressed in vitro wasconducted by a two-dimensional protein gel electrophor-
esis and is shown in Figures 4A and 4B. Intensity of indi-
vidual polypeptide spots was measured after gel
electrophoresis. For each polypeptide, the relative abun-
dance was calculated from individual spot intensity
against that of all measured polypeptide spots. The poly-
peptides that were expressed at significantly differential
levels in the two strains are summarized in Table 1. Out
of 591 polypeptide spots analyzed, 26 were found to have
at least a 10-fold increase in relative abundance in B31
than in N40D10/E9. On the other hand, 22 polypeptide
spots had at least a 10-fold increase in relative abundance
in N40D10/E9 than in B31. The increase in relative
abundance indicated that the polypeptides could be
uniquely expressed in a particular strain, or they could be
severely repressed in the other strain. One or more of the
proteins expressed uniquely in N40D10/E9 or at higher
levels in this strain during infection could contribute to
the higher level of infectivity and disease severity relative
to dose of infection of the N40D10/E9 strain.
To further evaluate the differences in the proteins that
are differentially expressed in the two strains, a limited
MALDI mass spectrometric (MALDI-MS) analysis of
selected protein spots was conducted. The proteins iden-
tified by MALDI-MS are listed in Table 1. Interestingly,
three protein spots of slightly different mobility, number
586 in B31 and numbers 272 and 293 in N40D10/E9,
were found to be more abundant (>650 times) than that
Figure 4 Two-dimensional gel electrophoresis of B31 and N40D10/E9 strains total proteins. Polypeptide spots with increased relative
abundance (more than 1.7 fold increase) in B31 versus N40D10/E9 are outlined in blue while spots with decreased relative abundance (more
than 1.7 fold decrease) in B31 versus N40 are outlined in red. Several of these spots were sent for MALDI-MS analysis.
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MALDI-MS analysis (Table 1) identified them as flagellin
proteins. We amplified the flagellin gene (bb0147) from
B31 and N40D10/E9 strains and sequenced the PCR
product from the N40 strain. Sequence analysis showed a
single amino acid change resulting in slight difference in
the pI of the two proteins. This could affect mobility of
the flagellin of each strain slightly on a 2D gel with each
appearing as more abundant protein relative to the other
B. burgdorferi strain (Figure 4 and Table 1).
N40D10/E9 is more infectious than B31 in
immunocompetent C3H mice
To determine if the B31 strain is more infectious and
pathogenic than our N40D10/E9 strain, we used the
susceptible C3H mouse infection model. By using dif-
ferent doses of B. burgdorferi strains injected subcuta-
neously into immunocompetent C3H mice, we
determined the relative infectivity of each strain. Two
weeks after inoculation, mice were euthanized, and dia-
meters of tibiotarsal joints measured. Cultures exam-
ined microscopically from the blood, skin at the
injection site, ear, joint, heart, and bladder were found
to be positive from fewer tissues for the B31 strain
than N40D10/E9 at a lower inoculum (Table 2) and
based upon these results, the calculated median infec-
tious dose (ID50) for B31 and N40D10/E9 were 371
and 46, respectively.
In addition to differences in the infectivity of these
two strains, mice injected with B31 appeared to manifest
less severe joint disease than those infected with
N40D10/E9, as evidenced by severe joint swelling exhib-
ited by this strain at lower doses of infection (Table 3
and Figure 5). This was further confirmed by histopatho-
logical examination of the joints of the infected mice,which indicated that N40D10/E9-infected mice devel-
oped severe joint disease at the lowest infectious dose
(101), whereas B31-infected mice primarily developed
arthritis at 103 and higher dose of infection of B. burg-
dorferi per mouse. Mice with joint disease had involve-
ment of the knees as well as of the tibiotarsal joints.
Tibiotarsal arthritis was characterized by the presence of
numerous infiltrating neutrophilic leukocytes in the peri-
articular tissue, tendons, ligaments, and synovial lining,
which was thickened due to proliferation of synovial
cells. Synovial lumina contained variable numbers of
exuded neutrophils (data not shown).
Discussion
Study of infectious bacterial species involving more than
one virulent strain provides a more complete picture of
the pathogenesis of the organism. B31 and N40 are two
of the most widely examined B. burgdorferi strains in the
USA to study Lyme disease pathogenesis. In 1997, B31
was the first B. burgdorferi genome that was published
[101]. We have recently determined that different la-
boratories use two different N40 strains under the same
strain name [29]. The genome of N40B was completed
recently [30] but is not fully published. Our N40D10/E9
clone derivative is not yet sequenced but our critical
evaluation has indicated that these two N40 strains are
quite different even though both of them were isolated
from the same tick [29]. Indeed, based upon RST and
ospC types, both N40 strains are predicted to be a much
less pathogenic strain than B31 [23,32,33,98-100]. How-
ever, at least in one study, a higher percentage of mice
infected with the sequenced N40 as compared to those
with B31 strain developed myocarditis (100% versus
92%). In addition, N40 showed both higher level of
colonization in joints and arthritic lesions than that by
Table 1 Polypeptide spots that showed at least a 10-fold increase in relative abundance in B31 or N40D10/E9 on 2D protein gel
Spot # pI MW
(kDa)
Relative abundance






Spot # pI MW
(kDa)
Relative abundance






33 6.2 88.96 0.036, 0.003 11.2 136 5.6 64.58 0.002, 0.029 14.7
110 5.1 63.92 0.050, 0.003 15.1 208 5.8 53.07 0.015, 0.340 22.7
127 5.3 65.24 0.037, 0.003 11.5 231 6.9 52.81 0.019, 0.226 11.8
211 6.1 55,65 0.875, 0.048 18.0 272 6.2 46.29 0.000, 0.054 685.4 *Flagellin (GI:120230),
Basic membrane
protein A (GI:3913169)
225 6.1 57.07 0.193, 0.005 35.3 293 6.0 43.53 0.000, 0.170 698.2 *Flagellin (GI:120230)
325 5.6 38.32 0.114, 0.010 11.3 311 6.0 39.99 0.005, 0.165 30.6
403 5.4 31.03 0.071, 0.002 29.1 347 6.0 35.06 0.003, 0.185 59.8
404 5.4 31.00 0.404, 0.003 124.1 OspD (GI:495462) 348 5.6 34.95 0.007, 0.258 36.3
405 5.5 28.78 1.006, 0.031 32.7 349 6.0 34.36 0.003, 0.095 32.4
458 5.7 26.07 0.051, 0.003 15.2 352 6.5 34.25 0.003, 0.034 12.0
463 6.5 25.58 0.107, 0.007 15.4 354 5.9 34.62 0.004, 0.207 47.9
465 6.3 25.49 0.077, 0.006 13.2 381 5.6 29.61 0.003, 0.032 10.4
491 7.0 22.69 0.356, 0.012 29.8 406 6.2 28.54 0.006, 0.081 14.0
494 6.5 23.16 1.400, 0.062 22.8 418 6.3 27.97 0.089, 1.927 21.6
495 6.7 23.13 6.875, 0.025 278.1 Outer surface
protein C (GI:3914248)




497 6.3 22.87 0.262, 0.022 12.1 479 6.4 24.51 0.060, 0.648 10.7
519 7.1 20.08 0.734, 0.027 26.8 501 6.5 22.47 0.030, 1.956 64.6 Same as 505
525 6.4 21.03 0.234, 0.008 30.9 Neutrophil activating
protein (GI:15595035)
505 6.3 22.33 0.017, 0.570 34.0 OspC (GI: 226246807) Neutrophil
activating protein (GI:15595035)
528 6.2 20.95 0.068, 0.004 15.9 517 6.2 21.41 0.002, 0.095 54.4
541 6.4 20.31 0.097, 0.005 20.8 543 5.6 19.67 0.006, 0.072 11.9
559 5.6 17.70 0.137, 0.008 17.2 551 6.2 19.51 0.075, 0.762 10.2
581 4.9 11.91 2.069, 0.048 42.7 6.6 kDa lipoprotein
(GI:1477781)
573 5.3 14.07 0.005, 0.255 55.0
585 6.3 28.02 0.125, 0.010 12.2
586 6.1 44.19 0.357, 0.001 674.8 *Flagellin (GI:120230)
587 6.1 44.41 0.209, 0.000 765.7
588 6.1 41.54 0.276, 0.001 527.4



















Table 2 Colonization of C3H mice tissues by B31 or N40D10/E9 strains examined two weeks after inoculation
Strain Inoculum Recovery of B. burgdorferi from mouse tissues ID50
Blood Injection site Ear Left joint Heart Bladder Total
B31 10 0/3 0/3 0/3 0/3 0/3 0/3 0/18
102 0/3 0/3 0/3 2/3 0/3 0/3 2/18 371
103 2/2 1/2 2/2 2/2 1/2 2/2 10/12
104 2/2 2/2 2/2 2/2 1/2 2/2 11/12
N40 10 1/3 2/3 2/3 0/3* 1/3 2/3 8/18
102 3/3 2/3 2/3 0/3* 2/3 2/3 11/18 46
103 2/2 2/2 2/2 0/2* 1/2 2/2 9/12
104 2/2 2/2 2/2 1/2 1/2 2/2 10/12
Asterisks indicate that the cultures were contaminated.
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Such a comparative study has not been carried out with
our N40D10/E9 strain. Therefore, we conducted thor-
ough comparative analyses both in vitro and in vivo to
assess their infectivity and ability to colonize various tis-
sues and cause disease.
B. burgdorferi strains have been shown previously to
bind to various mammalian cell types in vitro and
in vivo [58,60-64]. In this study, we selected Vero, EA.
hy926, C6 glioma, and T/C-28a2 as representatives of
epithelial, vascular endothelial, glial, and chondrocyte
cells to study adherence of spirochetes in vitro. With the
exception of Vero epithelial cells, B. burgdorferi strain
B31 and strain N40D10/E9 showed approximately the
same level of in vitro binding to various mammalian
cells in this study. These results indicate the two most
studied B. burgdorferi strains, B31 and N40D10/E9, ex-
hibit some differences in adherence despite sharing simi-
lar capability and mechanisms for adherence to various
mammalian cells in vitro.
Binding of B31 is significantly higher on Vero cells
than N40D10/E9, but heparinase I treatment of these
cells reduced binding of N40 strain much moreTable 3 Tibiotarsal joint swelling and histological examinatio










Joint swelling of each dose was quantitated by average diameter of the right tibiot
scored from “-” (no arthritis) to “+++ (3+)” (severe arthritis) in the tibiotarsus for infe
recorded as “-” (no arthritis) to “+” (arthritis) of each infected mouse.dramatically (Figures 1A and 1B). These results suggest
that a higher expression of surface proteins in B31 than
N40D10/E9 that show affinity for host receptors other
than heparan sulfate may be facilitating the attachment
of this strain to Vero cells. Indeed, our study identifies
BBK32 as one such candidate. N40B and cN40 contain
both lp36 and BBK32 while our N40D10/E9 strain lacks
lp36. It is possible that the BBK32 homolog in N40D10/
E9 was significantly different from the BBK32 of B31
both at DNA and protein level, and hence, may not
carry out the same functions. This can also explain a
higher level of binding of B31 strain to Vero cells and
potentially other cell lines that are not part of this study
since in addition to its ability to recognize GAGs,
BBK32 is also a fibronectin-binding protein [41,53].
Interestingly, the N40 strain with published sequence is
different from our N40D10/E9 clone. The sequenced
N40 contains a bbk32 gene, which is similar to the
bbk32 of B31 with 96% identity and 97% similarity with
the B31 protein. In another study, we have shown that
lp36, which contains the bbk32 gene in the B31 strain, is
missing only in our N40 strain [29]. It is likely that the






-, ±, + -, -, -
-, ±, + -, -, + (Tc)
3+, 3+ +, +,
3+, 3+ +, +
-, 2+, 3+ -, +, +
+, 2 to 3+, 3+ +(Tc), +, +
3+, 3+ +, +,
3+, 3+ +, +
arsal joint of multiple mice with each dose group. Joint inflammation was
cted mice at each inoculation dose. Knee or Tibial crest (Tc) inflammation was
Figure 5 Tibiotarsal joint inflammation in C3H mice inoculated
with the N40D10/E9 and B31 strains. C3H mice were inoculated
with a different inoculum dose (10, 102, 103, 104 spirochetes) of B31
or N40D10/E9 strains. (A) Two weeks after injection, severe tibiotarsal
joint swelling was evident only in mice infected with 103 or 104 of
B31. (B) However, severe tibiotarsal joint swelling could be observed
in mice infected with 10, 102, 103 or 104 of N40D10/E9.
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strain, and not of N40D10/E9. BBK32 may recognize
fibronectin as a component of the extracellular matrix of
the Vero cells.
A predicted higher pathogenicity of the B31 strain
relative to the N40D10/E9 strain based-upon RST and
ospC grouping contradicts both our results and the find-
ings of other researchers, who have used N40 strains
[23,35,105,106]. Thus, RST and one virulence factor
(ospC) sequence comparison may be important for
phylogenetic analysis but may not be suitable for draw-
ing conclusions about the pathogenicity of a particular
strain of B. burgdorferi without assessment of the viru-
lence factors or actually conducting the experiments.
However, due to development of genetic manipulation
techniques for B. burgdorferi only in the last decade, the
roles of only a few virulence factors have been deter-
mined, and a comprehensive analysis of multi-virulence
loci of B31 and N40D10/E9 strains is not yet possible.
Furthermore, a full repertoire of the virulence factors for
Lyme spirochetes is still not determined even on the
basis of the sequence homology with genes of otherpathogens since spirochetes contain most unique genes
[101,107]. Finally, genetic manipulation and evaluation
of mutant B. burgdorferi strains remains very time con-
suming and difficult. Therefore, the pathogenicity of B31
and N40D10/E9 cannot be determined simply by multi-
virulence locus sequence typing (MVLST) at present
similar to that used for other pathogenic bacteria
[5,6,108]. Therefore, we used an alternative approach to
investigate the functions relevant to tissue colonization
of B31 and N40D10/E9 strains in vitro and examined
their virulence in the mouse model. Interestingly, even
though it was possible to determine the molecular basis
of adherence using the mammalian cell lines, we did not
see a direct correlation of the ability of these strains to
adhere to the mammalian cells in vitro and infectivity or
pathogenicity in the mouse host. However, it is possible
that a lower adherence of the N40D10/E9 strain to epi-
thelial cells at the site of inoculation enhances its
dissemination to different tissues. These findings indi-
cated that both in vitro and in vivo complementary
approaches should be used to study different aspects
of host-bacterial interactions and relevant determina-
tions made without making generalized conclusions or
extrapolations.
For further molecular differentiation of these two
strains that may provide a possible hint about the dif-
ferences we saw in their infectivity, we used PCR to
determine the presence of genes encoding known viru-
lence factors and associated proteins identified using a
genetic approach in the last decade. We also evaluated
the protein profiles of B31 and N40D10/E9 strains
grown in vitro. Comparison of these two gels errone-
ously identified flagellin gene as different protein spots.
This was depicted in the Table 1 as >650-fold change
in the level of protein relative to the other strain.
MALDI-MS analysis of the protein spots and sequence
analysis of the N40D10/E9 flagellin gene were able to
resolve this issue. The mobility shift of the flagellin in
two gels is likely due to a single amino acid change
resulting in slight difference in the pI of protein in
B31 and N40D10/E9 strains. In addition to BBK32,
comparative 2D-protein gel electrophoresis analysis
revealed a large number of proteins that were uniquely
expressed in either the B31 or N40D10/E9 strain. Sev-
eral of these proteins have been identified. For ex-
ample, the outer surface protein D (OspD, polypeptide
spot 404 in Table 1) is highly expressed in B31 but
not in N40. OspD has been shown to be responsible
for colonization of B. burgdorferi in the tick gut
[109,110]. However, OspD is not essential for transmis-
sion of the spirochete from tick to mouse or during
the infection of the mouse [109,110]. In the N40D10/
E9 strain, expression of the outer surface protein C
(OspC and/or neutrophil activating protein spots 501
Chan et al. BMC Microbiology 2012, 12:157 Page 11 of 16
http://www.biomedcentral.com/1471-2180/12/157and 505 in Table 1) is expressed at much higher levels
compared to that in the B31 strain. OspC lipoprotein
is required for successful early stages of mouse infec-
tion [111], and one study suggests that OspC can fa-
cilitate dissemination of B. burgdorferi during mouse
infection [76]. Investigation of the expression of the
proteins of the N40D10/E9 strain, which are expressed
at higher levels in vitro, also in the host-adapted spiro-
chetes may shed light on the virulence factors that
contribute to the higher infectivity of the N40D10/E9
strain during mouse infection. These will form the
foundation of future studies to identify other important
virulence factors of B. burgdorferi using extensive mo-
lecular and genetic approaches.Conclusion
We conclude that N40D10/E9 is more infectious in C3H
mouse model than B31 when a lower dose of inoculation
is used for needle injection while both strains are highly
pathogenic in this model system. Our studies also indi-
cate that phylogenetic analysis is not sufficient but a
comprehensive appraisal of virulence and critical regula-
tory factors as well as their evaluation in vivo should be
used to determine pathogenesis of a particular Lyme
spirochete strain. Furthermore, it is suggested that mul-
tiple strains should be used to fully understand the infec-
tion and pathogenic mechanisms involved in Lyme
disease manifestations since some invasive strains may
possess or express specific virulence factors differentially.Methods
Bacterial strains and cell lines
B315A4 clones were obtained from the laboratory of
Steven Norris at University of Texas, Houston. The
N40D10/E9 strain was originally cloned and provided by
John Leong at Tufts University Medical School, Boston.
Low passage (less than six) B. burgdorferi strains B31
and N40 (from original clone D10/E9) were grown in
Barbour-Stoenner-Kelly-II (BSK-II) medium [112] sup-
plemented with 6% rabbit serum at 33°C.
Various mammalian cell lines for this study were cul-
tured according to recommended conditions originally
provided by the suppliers. Vero (monkey kidney epithelial)
cells were cultured in RPMI 1640 supplemented with 10%
NuSerum IV (BD Biosciences, Franklin Lakes, NJ). EA.
hy926 (human endothelial) cells were cultured in DMEM
supplemented with 10% fetal bovine serum (FBS) and 1%
HAT nutrient supplement (Invitrogen, Carlsbad, CA). C6
(rat) glial cells were cultured in RPMI 1640 supplemented
with 8% FBS. T/C-28a2 (human chondrocyte) cells [69]
were cultured in a 1:1 mix of DMEM and Ham’s 12
medium supplemented with 10% FBS. All mammalian
cells were grown at 37°C in 5% CO2 atmosphere.Radioactive labeling of B. burgdorferi
B. burgdorferi strains were labeled with 35 S isotope as
previously described [38]. Briefly, B. burgdorferi was cul-
tured in BSK-II medium supplemented with 6% rabbit
serum and 100 μCi/ml [35 S] -cysteine and -methionine
protein labeling mix (Perkin-Elmer, Waltham, MA) at
33°C until the density was between 5 × 107 and 1 × 108
spirochetes per ml. The bacteria were harvested by cen-
trifugation at 5000 × g for 20 minutes, and then washed
three times with PBS supplemented with 0.2% BSA. La-
beled B. burgdorferi were resuspended in BSK-H
medium (Sigma-Aldrich, St. Louis, MO) containing 20%
glycerol, with a final spirochete density of 1-2 × 108 per
ml, and stored in aliquots at −80°C.
Attachment of radiolabeled B. burgdorferi
to mammalian cells
Binding of B. burgdorferi to mammalian cells was quan-
tified according to procedures described previously [62].
One or two days prior to the assay, mammalian cells
were lifted and plated in 96-well break-apart microtiter
plates coated with 2 μg/ml Yersinia pseudotuberculosis
recombinant purified invasin protein [113]. On the day
of the experiment, frozen aliquots of radiolabeled B. burg-
dorferi were thawed and resuspended in 1.8 ml of BSK-H
medium without serum and then incubated for 2 hours at
room temperature to allow for physiologic recovery of the
bacteria. B. burgdorferi were then diluted 1:3 in 10 mM
HEPES, 10 mM glucose, 50 mM NaCl (pH 7.0). The spir-
ochetes were checked for intact morphology and vigorous
motility. Before adding bacteria, the confluent monolayer
of mammalian cells was washed twice with PBS. To pro-
mote host cell-bacterium contact, the microtiter plates
were centrifuged at 190× g for 5 minutes at 23-24°C and
then gently rocked at 24°C for 1 hour. Unbound bacteria
were removed by washing the monolayers three times in
PBS supplemented with 0.2% BSA. Cells integrity was
checked microscopically and bound bacteria were quanti-
fied by scintillation counter. Four replicates were used for
each treatment in these experiments.
To determine the effect of enzymatic removal of
GAGs from host cells surface on B. burgdorferi attach-
ment, the monolayers were incubated at 37°C for 2
hours with 0.5 U/ml of heparinase I (H2519), or chon-
droitinase ABC (C3667) (Sigma-Aldrich, St. Louis, MO)
in RPMI 1640 supplemented with 1% BSA, 10-2 trypsin
inhibitory units per ml of aprotinin, and 150 μg/ml of
phenylmethylsulfonyl fluoride (PMSF). The monolayers
were washed twice with PBS, and then binding assay
with the radiolabeled bacteria was conducted as
described above. All binding experiments were con-
ducted at least three times and data from one represen-
tative experiment are presented in the Figures 1 and 2.
T-test for samples with unequal variance was used to
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a specific treatment was statistically significant relative
to the Mock treatment.
PCR-amplification of major known plasmid-borne genes
encoding virulence factors of B. burgdorferi
The genes encoding virulence factors that have been iden-
tified by several researchers previously were amplified by
PCR using Taq DNA polymerase under the following con-
ditions: initial denaturation at 95°C for 2 minutes, 35
cycles of denaturation at 94°C for 1 minute, annealing at
40°C or 50°C for 1 minute, extension at 65°C for 1 minute,
and final extension at 72°C for 10 minutes. Genomic DNA
of B31 and N40D10/E9 strains were used as PCR tem-
plates. Primers were designed based upon published B31
sequences [101] and are listed in Additional file 1: Table S1.
Southern hybridization of genomic DNA of B31 and
N40D10/E9 strains digested with EcoRI with bbk32 gene
as a probe
Genomic DNA of B31 and N40D10/E9 strains were
digested with EcoRI enzyme overnight at 37°C and
digested DNA was resolved by agarose gel electrophor-
esis. DNA in the gel was then transferred to a Nytran
SPC nylon membrane (Whatman, Piscataway, NJ) in al-
kali transfer buffer (0.4 M NaOH). The bbk32 gene was
amplified from the B31 strain by PCR as described
above. The resulting PCR amplicon was labeled with
digoxigenin-dUTP by random priming. DIG high prime
DNA labeling and detection starter kit II (Roche Applied
Science, Indianapolis, IN) was used for probe prepar-
ation, Southern hybridization, and immunological
chemiluminescent signal detection. All procedures were
conducted according to manufacturer’s instruction.
Two-dimensional electrophoresis of total proteins from
B31 and N40D10/E9 strains
Fifty micrograms of total proteins extracted from B.
burgdorferi strains B31 and N40D10/E9 were lyophilized
and redissolved to 1 mg/ml in 1:1 diluted SDS boiling
buffer:urea sample buffer before loading. Two-
dimensional electrophoresis was performed using the
carrier ampholine method of isoelectric focusing
[114,115] by Kendrick Labs, Inc. (Madison, WI). Isoelec-
tric focusing was carried out in a glass tube of inner
diameter 2.3 mm using 2% pH 4–8 mix Servalytes
(Serva, Heidelberg Germany) for 9,600 volt-hrs. Fifty
nanograms of an IEF internal standard, tropomyosin was
added to the sample. This protein migrates as a doublet
with lower polypeptide spot of MW 33,000 and pI 5.2.
After equilibration for 10 min in Buffer 'O' (10% gly-
cerol, 50 mM dithiothreitol, 2.3% SDS and 0.0625 M tris,
pH 6.8), each tube gel was sealed to the top of a stacking
gel that overlaid a 10% acrylamide slab gel (0.75 mmthick). SDS slab gel electrophoresis was carried out for
about 4 hrs at 15 mA/gel. The following proteins (Sigma-
Aldrich, St. Louis, MO) were used as molecular weight
standards: myosin (220,000), phosphorylase A (94,000),
catalase (60,000), actin (43,000), carbonic anhydrase
(29,000) and lysozyme (14,000). These standards appear
along the basic edge of the silver-stained [116] 10% acryl-
amide slab gel. The silver stained gels were dried between
sheets of cellophane with the acid edge to the left side.
Duplicate gels were obtained from each sample and
were scanned with a laser densitometer (Model PDSI,
Molecular Dynamics Inc, Sunnyvale, CA). The scanner
was checked for linearity prior to scanning with a cali-
brated Neutral Density Filter Set (MellesGriot, Irvine,
CA). The images were analyzed using Progenesis Same
Spots software (version 4.0, 2010, Nonlinear Dynamics)
and Progenesis PG240 software (version 2006, Nonlinear
Dynamics, Durham, NC). Selected spots were cut out
and limited MALDI mass spectrometric (MALDI-MS)
analyses were conducted at the Protein Core Facility of
Columbia University at New York.
In-gel digestion of proteins
Gel spots were transferred to clean tubes, water was
added to completely hydrate gels, and the plastic coating
was removed with clean tweezers. Gel spots were pre-
pared for digestion by washing twice with 100 μl of
0.05 M Tris, pH 8.5/30% acetonitrile for 20 minutes with
shaking, then with 100% acetonitrile for 1–2 min. After
removing the washes, the gel pieces were dried for 30
minutes in a Speed-Vac concentrator. Gels were digested
by adding 0.08 μg modified trypsin (sequencing grade,
Roche Molecular Biochemicals) in 13-15 μl 0.025 M
Tris, pH 8.5. The tubes were placed in a heating block at
32°C and left overnight. Peptides were extracted with 2X
50 μl of 50% acetonitrile/2% TFA; the combined extracts
were dried and resuspended in matrix solution.
MALDI-MS analysis
Matrix solution was prepared by making a 10 mg/mL
solution of 4-hydroxy-α-cyanocinnamic acid in 50%
acetonitrile/ 0.1% TFA and adding two internal stan-
dards, angiotensin and ACTH 7–38 peptide, to the
matrix solution. The dried digest was dissolved in 3 μl
matrix/standard solution and 0.5 μl was spotted onto
the sample plate. When the spot was completely dried, it
was washed twice with water. MALDI-MS analysis was
performed on the digest using an Applied Biosystems
Voyager DE Pro mass spectrometer in the linear mode.
Peptide mass search
Average peptide masses were entered into search pro-
grams to search the NCBI and/or GenPept databases for
a protein match. Programs used were Mascot at www.
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edu. Cysteine residues were modified by acrylamide.
Parameters for web-based search using Mascot were
as follows: Database: NCBI; Taxonomy: bacteria; Variable
modifications: Oxidation (M), Carboxyamidomethyl (C);
Missed cleavages: 2; Error tolerance for Peptide average
masses: 0.5 Da. Parameters for web-based search using
MS-FIT were as follows: Database: NCBI; Taxonomy:
bacteria; Constant mods: Possible mods: Oxidation of
M; Minimum number of peptides to match: 4.Mouse model of infection
Four-week old C3H/HeN female mice (Charles River La-
boratories, Wilmington, MA) were inoculated subcuta-
neously on the top of the right hind leg on the dorsal
side at a dose of 10, 102, 103 or 104 B. burgdorferi strain
B31 or N40D10/E9 in each mouse with the first two
dose groups containing three mice each. Higher doses of
infection (103 and 104 per mouse) were used to inoculate
two mice each. After 14 days of infection, mice were
euthanized and blood collected. Skin at the inoculation
site, ear as a site for disseminated skin infection, heart,
urinary bladder, and one joint were transferred to tubes
containing BSK-II medium supplemented with 6% rabbit
serum and antibiotic mixture for Borrelia (Sigma-
Aldrich, St Louis, MO) and grown at 33°C. The median
infectious doses (ID50) for B31 and N40D10/E9 were
determined by examination of cultures from the mouse
tissues.
Joint disease severity was determined by measuring
the diameters of the tibiotarsal joints with a caliper and
pictures taken. For histological examination, joints of
infected mice were fixed in neutral buffered formalin,
processed by routine histological methods, and scored
blindly for arthritis severity, as described [117]. This
work was conducted by the histology core facility of
New Jersey Medical School. UMDNJ-New Jersey Med-
ical School is accredited (Accreditation number 000534)
by the International Association for Assessment and Ac-
creditation of Laboratory Animals Care (AAALAC Inter-
national), and the animal protocol used was approved by
the Institutional Animal Care and Use Committee
(IACUC) at UMDNJ.Additional file
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